Update: Atlas Blockchain to Acquire Isracann Biosciences Inc. and Complete Concurrent Financing for Up to $15 Million

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 16, 2018 (GLOBE NEWSWIRE) — Atlas Blockchain Group Inc.  (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) today provides an update detailing term particulars concerning a proposed concurrent financing as previously announced on October 11, 2018

Continue reading